Epidemiology and Genomic Surveillance of Staphylococcus Aureus in ICU Neonatology (NEOSAUR)

C

Caen University Hospital

Status

Not yet enrolling

Conditions

the Aim of This Study is to Describe Genomic Epidemiology of MSSA in Neonatal ICU

Study type

Observational

Funder types

Other

Identifiers

NCT06267352
230097

Details and patient eligibility

About

Newborns hospitalized in Neonatology are particularly vulnerable to infections, in particular healthcare associated infection (HAI). Staphylococcus aureus represents the 2nd microorganism responsible for sepsis, this infection is particularly serious and like any HAI, it increases the length of hospitalization of newborns and neonatal morbidity. In September 2020, the CDC published recommendations for the prevention and control of Staphylococcus aureus infections in neonatal intensive care unit/ICU. They specify the indications for implementing a MSSA surveillance strategy as well as the screening and management methods. Despite the absence of a defined strategy at the national level, our establishment chose to initiate management measures several years ago following serious infections and MSSA epidemics in neonatal intensive care unit/ICU. With the aim of improving the efficiency of care and evaluating the strategy chosen at the establishment, it is necessary to describing the epidemiology of MSSA carriage and infections cross-transmission of MSSA strains between patients the success rate of decolonization the sensitivity of detection of digestive carriage by stool swabbing in order to limit the number of samples from newborns.

Enrollment

120 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • newborns hospitalized in neonatal ICU
  • MSSA carrier

Exclusion criteria

none

Trial contacts and locations

0

Loading...

Central trial contact

Camille JEANNE-LEROYER

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems